Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
- 1 November 1994
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 344 (8935), 1470-1472
- https://doi.org/10.1016/s0140-6736(94)90290-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Chemotherapy for Colorectal CancerNew England Journal of Medicine, 1994
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.The Journal of cell biology, 1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44Science, 1992
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- Adjuvant Therapy for Patients With Colon and Rectal CancerJAMA, 1990